Diagnostic accuracy
Could a blood microRNA test help diagnose tuberculosis?
Open access · cc by · source: Europe PMC
A few small RNA molecules were raised in the blood of people with active tuberculosis and could separate them from healthy people moderately well, but the finding is preliminary.
Study at a glance
- Design
- Case-control — Two-stage diagnostic case-control study: pooled-serum microRNA array screen, then individual-sample qRT-PCR validation with ROC analysis
- N
- Participant counts are inconsistent in the text: Methods list 155 participants (30 active TB, 65 healthy controls, plus 60 paediatric sera with other infections), while Results say 65 participants including 30 TB patients and 65 controls; the array stage used pools of 20 TB and 20 control sera
- Population
- HIV-negative adults with untreated smear-positive pulmonary TB and healthy check-up attendees in Jiangsu Province, China; comparison pools from children with pertussis, varicella-zoster or enterovirus infection
- Outcome
- Serum microRNA levels and their ability to distinguish TB from controls (area under the ROC curve)
Structured fields used in claim comparison tables when every cited study has a complete layer.
Key findings
The array flagged 97 microRNAs that differed at least two-fold (90 higher and 7 lower in TB). Seven of the ten candidates were confirmed as raised by PCR, but only three separated the groups reasonably: miR-361-5p (AUC 0.848), miR-889 (AUC 0.765) and miR-576-3p (AUC 0.711). Combining the three barely improved accuracy (AUC 0.863), and these three also differed between TB and the other-infection pools.
Methodology
The researchers pooled serum from 20 patients with confirmed, untreated pulmonary TB and 20 healthy controls and screened 667 microRNAs on an array to find ones that differed. They picked the ten most strongly raised candidates and measured them in individual samples by quantitative PCR, then used ROC curves to judge how well each one, and a combination, distinguished TB patients from controls. Serum pools from children with three other infections were used to check whether the signals were specific to TB.
Limitations
This is an early discovery study, not proof of a usable test: cases were clear-cut smear-positive patients compared with healthy people, which tends to overstate accuracy compared with real clinical use, and no separate validation cohort was tested. Latent TB and patients with other lung diseases were not studied, and the other-infection comparison used pooled serum from children rather than individual adults. The reported participant numbers are internally inconsistent, and the authors themselves describe the diagnostic ability as only moderate and call for larger studies.
How this study connects
Role on claims
Each row is a claim on a concept or method page where this paper supports, challenges, or qualifies the statement. Roles are hand-checked — not a model guess.
Not yet placed on a claim. This paper has study layers, but no concept page yet cites it as support, challenge, or qualifier.
Related papers in this topic
Same topic cluster — not a recommendation engine.